Skip to main content
TipRanks
Go Ultimate75% OFF

Oliver Francis Wintour James Insider Profile

4 Followers

Oliver Francis Wintour James, former Director at E Therapeutics, holds 145.31K shares in E Therapeutics (Ticker: GB:ETX).

Oliver Francis Wintour James's Trading History

ETX
E Therapeutics
Aug 01, 2014―Uninformative Buy2.70K£13.08K
GB:ETX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 01, 2014Uninformative Buy£2.70K9,075£30.00――
Jun 26, 2014Uninformative Buy£2.70K9,819£28.00――
Aug 02, 2013Uninformative Buy£2.70K7,660£35.00――
Feb 22, 2013Uninformative Buy£2.70K8,256£33.00――
Aug 06, 2012Uninformative Buy£2.70K7,500£36.00――

You May Also Like

Oliver Francis Wintour James insider profile FAQ

What is the percentage of profitable transactions made by Oliver Francis Wintour James?
The percentage of profitable transactions made by Oliver Francis Wintour James is 100%.
What is the average return per transaction made by Oliver Francis Wintour James?
The average return per transaction made by Oliver Francis Wintour James is 21.90%.
What stocks does Oliver Francis Wintour James hold?
Oliver Francis Wintour James holds: GB:ETX stocks.
What was Oliver Francis Wintour James’s latest transaction?
Oliver Francis Wintour James’s latest transaction was an Uninformative Buy of 2.70K .
What was Oliver Francis Wintour James's most profitable transaction?
Oliver Francis Wintour James’s most profitable transaction was an Informative Buy of GB:ETX stock on March 11, 2009. The return on the trade was 43.80%.
What is Oliver Francis Wintour James's role in E Therapeutics?
Oliver Francis Wintour James's role in E Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.